Search Results

A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.

A study supports a greatly expanded treatment program for parasitic worm diseases that could save millions from disability and possible death in sub-Saharan Africa.

People disabled by a stroke demonstrated substantial recovery long after the event when modified adult stem cells were injected into their brains.

Artificial collagen-based muscle fibers and a specialized broth developed by Stanford researchers help muscle stem cells stay primed and ready for transplant.

A Stanford-led national collaboration to procure and analyze human pancreatic tissue from deceased donors illustrates how the organ’s function changes as we age, and could point the way toward new diabetes treatments.

Doxorubicin is a chemotherapy drug used to treat many cancers, but it causes serious heart damage in some patients. Heart muscle cells made from the skin cells of breast cancer patients can be used to study this phenomenon.

People with cancer have tumor DNA in their blood. A new way to quiet background “noise” in the blood sample allows researchers to sequence minute quantities of these molecules to improve diagnosis and treatment.

Researchers have identified a link between the expression of a cancer-related gene and cell-surface molecules that protect tumors from the immune system.

Nearly 30 years after the discovery of the hematopoietic stem cell, Stanford researchers have found a marker that allows them to study the version of these stem cells that continues to replicate.

A small subset of colon cancers lacks the CDX2 protein — a hallmark of colon tissue maturation. Patients with these cancers may benefit more than others from chemotherapy.